BASL Winter Meeting 2017

Friday, December 1st

08.30-09.00  Registration

09.00-10.20  Session 1 : Hepatocellular carcinoma

Moderators: Jean Delwaide, Anja Geerts

  1. New emergent therapies in advanced hepatocellular carcinoma:
    C Verslype (KULeuven) 
     
  2. Place of radioembolisation in hepatocellular carcinoma in 2017
    Elisabeth Dhondt (UZGhent)
     
  3. Relevance of Pet-scan and other imaging modalities in Hepatocellular carcinoma
    Renaud Lhommel (UCL)

10.30-11.00  COFFEE BREAK

11.00-12.30  NON-INTERACTIVE DISCUSSION OF CLINICAL CASES

Moderators:  C Van Steenkiste, P Stärkel

6-8 cases

12:30-12:50  Presentations BASL YOUNG INVESTIGATORS AWARD LAUREATES 2017 and short presentation by 2016 Laureates     

12.50-13.00 MSD Awards 2017: Best clinical and basic publication 2016         

13.00-14.00  LUNCH

14.00-15.15  Session 2:  HEPATOLOGY UPDATE 

Moderators : Sergio Negrin-F Nevens

  1. Endoscopic treatment of PSC: Is there something new?
    Arnaud Lemmers (ULB)
     
  2. Management of severe alcoholic hepatitis after STOPAH trial
    Mark Thursz (London, UK) 
     
  3. Diagnosis and management of malnutrition and sarcopenia in cirrhosis
    Ger Koek (Maastricht) 

15.15-16:45  TOPIC 3 : VIRAL HEPATITIS 

Moderators: JP Mulkay, F Sermon

  1. Management of Hepatitis C related extra-hepatic manifestations in the era of DAA
    Patrice Cacoub (Paris) 
     
  2. Hepatitis E: when to think about? How to treat?
    H Wedemeyer (Hannover) 
     
  3. When to stop NUCs in chronic hepatitis B: Are Belgian reimbursement criteria adequate?
    T Vanwolleghem (UZA)

16:45   CONCLUSIONS & FAREWELL


Saturday December 2nd: NAFLD-NASH

8:30-10:30

Moderators:  L Verbeeke (KUL), C Moreno (ULB)

  1. Epidemiology of NASH: is it really such a burden in Belgium?
    prof. Sven Francque, UZA
     
  2. How to diagnose NASH: invasive vs. non-invasive techniques.
    prof. Nicolas Lanthier, UCL
     
  3. NASH and ‘lean NASH’: when and how to consider alternative diagnosis.
    prof. David Cassiman, UZ Leuven
     
  4. Pathophysiology of NASH: a general overview.
    prof. Isabelle Leclercq, UCL

10:30-11:00  COFFEE BREAK

11:00-12:30

Moderators:  A Putignano (ULB), S Francque (UZA)

  1. Hepatocellular carcinoma in NASH: a challenging issue.
    prof. Hans Van Vlierberghe, U Gent
     
  2. Bariatric surgery in NASH: results, indications and contra-indications.
    prof. Guillaume Lasailly, Lille, France
     
  3. Treatment for NASH: novel therapies in the pipeline.
    prof. Vlad Raziu, Paris, France
Fri, 2017-12-01 (All day) to Sat, 2017-12-02 (All day)

Address

AuditoRium4 - Communicatiecampus (gebouw 485)
Sint-Denijslaan 485
9000 Gent
Belgium
BE
Registration info: 

MEMBERS
Free

NON-MEMBERS
75 euro (2 days)

IN TRAINING
25 euro

BANK ACCOUNT NUMBER
IBAN BE69 0013 4462 1878

Accreditation: 

Accreditation without grades for ethics and economics